Search NLS News

Orexo has announced positive results from the first explorative human clinical study for its nasal epinephrine (adrenaline) rescue medication for allergic reactions, OX640. The study was a comparative bioavailability study performed in 40 healthy volunteers assessing four investigational formulations of OX640 compared to a marketed epinephrine auto-injector. “The study results are truly exciting, and I […]

A fascination for the brain and psychiatric disorders led Haraldur Þorsteinsson to neurobehavioral science and research, and to found a company dedicated to accelerate the development of neurological innovative drugs within the field. Haraldur Þorsteinsson has always been fascinated by psychology and the brain. While working in a psychiatric hospital as a student he became […]

The Novo Nordisk Foundation is expanding and extending its Interdisciplinary Postdoctoral Fellowship Programme, thereby enabling ambitious researchers in the natural and technical sciences and life sciences to boost their careers with a research stay at one of several top international universities. The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek […]

The company has entered a collaboration agreement with Timothy J. Garrett Laboratory, College of Medicine, University of Florida. Dr. Tim Garrett is one of the leading experts and an authority in the US when it comes to applying mass spectrometry within the area of metabolomics and its clinical applications. He has a huge network of […]

The U.S. Food and Drug Administration (FDA) has granted the company’s Investigational New Drug (IND) application for the investigational drug RMC-035 (ROSgard). The approval enables expansion of the clinical development program for RMC-035 to the US, including the ongoing global and placebo-controlled Phase 2 study AKITA in cardiac surgery, states the company in its press […]

Ultimovacs has announced continuing positive efficacy data in its ongoing US-based phase I clinical trial, UV1-103. The study evaluates the company’s universal cancer vaccine, UV1, in combination with the anti-PD-1 checkpoint inhibitor pembrolizumab, as first-line treatment in advanced non-resectable and metastatic malignant melanoma patients. “Given the historic trajectory for patients with metastatic malignant melanoma, this […]

The World Health Organization (WHO) has made a Medical Product Alert that refers to four substandard (contaminated) products, identified in The Gambia and reported to WHO in September 2022. The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. The stated manufacturer of these products […]

Evaxion Biotech has announced that its new Chief Executive Officer (CEO) Per Norlén has joined the company on October 3rd. “With Per at the steering wheel, we expect to bring our promising clinical and preclinical results to the next level. Evaxion is a profoundly innovative and talented company working tirelessly to save patients’ lives. Per […]

The center will be the seventh specialized diabetes centre supported by the Novo Nordisk Foundation. A Steno Diabetes Center has been established in each of the five administrative regions in Denmark and one in Greenland, and now all the Danish realm is covered. They aim to ensure that people with diabetes have access to the […]

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry to Carolyn R. Bertozzi, Stanford University, USA, Morten Meldal, University of Copenhagen, Denmark, and K. Barry Sharpless, Scripps Research, USA. Carolyn R. Bertozzi (born 1966 in USA) has a PhD (1993) from UC Berkeley. She is currently Anne T. and […]